Professor Matthew Gentry from the University of Kentucky gives a presentation at the inaugural Challenging Childhood Dementia Symposium in March 2022. He describes the collaborative effort by the Lafora Epilepsy Cure Initiative consortium to understand Lafora disease and develop therapies. His talk focuses on the antibody-enzyme fusion (VAL-0417) which has been successfully tested in a disease model.
13 авг 2024
